Pathology Analysis & Statistics, May 2013

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1-30 of 40 reports

Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff

$ 3 500
Industry report
March 2013
by GBI Research

Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff Summary GBI Research, the leading business ...

Industries : Pathology
Countries : World, Italy, Germany, Japan, Spain, France, Europe, United States, United Kingdom

Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential

$ 3 500
Industry report
January 2013
by GBI Research

Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential Summary GBI Research has released its latest research, ?Acquired ...

Industries : Pathology
Countries : Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom

Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need

$ 3 500
Industry report
January 2013
by GBI Research

Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology
Countries : Spain, Italy, France, Germany, Japan, World, Europe, United States, United Kingdom

Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs% Major Market Share

$ 3 500
Company report
November 2012
by GBI Research

Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share Summary GBI Research, the leading business intelligence provider, has released its latest ...

Industries : Pathology
Countries : World

Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans

$ 3 500
Industry report
September 2012
by GBI Research

Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans Summary GBI Research, the leading business intelligence provider has released its latest ...

Industries : Pathology
Countries : United States

Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise

$ 3 500
Industry report
July 2012
by GBI Research

Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cance ...

Industries : Pathology

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

$ 3 500
Industry report
May 2012
by GBI Research

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business ...

Industries : Pathology
Countries : World

Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion

$ 3 500
Industry report
April 2012
by GBI Research

Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology
Countries : World

Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies

$ 3 500
Industry report
April 2012
by GBI Research

Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies Summary GBI Research's report "Herpes Market to 2018 - Genericization Compels ...

Industries : Pathology
Countries : World

Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future

$ 3 500
Industry report
March 2012
by GBI Research

Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future Summary GBI Research's new report, ?Urological Disorders Therapeutics ...

Industries : Pathology
Countries : World

Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher's and Niemann-Pick Poised to Supersede Existing Therapies

$ 3 500
Industry report
March 2012
by GBI Research

Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher's and Niemann-Pick Poised to Supersede Existing Therapies Summary GBI Research has released its latest research, ...

Industries : Pathology
Countries : World

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success

$ 3 500
Industry report
February 2012
by GBI Research

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology
Countries : World

Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules

$ 3 500
Industry report
January 2012
by GBI Research

Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules Summary GBI Research, ...

Industries : Pathology
Countries : World

ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance

$ 3 500
Industry report
January 2012
by GBI Research

ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance Summary GBI Research, the leading business intelligence provider, has ...

Industries : Pathology
Countries : World

Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma

$ 3 500
Industry report
January 2012
by GBI Research

Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma Summary GBI Research, the leading business intelligence provider, has released its latest ...

Industries : Pathology
Countries : World

Hospital Acquired Bacterial Infections Market to 2017 - Niche Players are Most Active in R&D, Positioning Them as Potential Acquisition Targets for Big Pharma

$ 3 500
Industry report
December 2011
by GBI Research

Hospital Acquired Bacterial Infections Market to 2017 - Niche Players are Most Active in R&D, Positioning Them as Potential Acquisition Targets for Big Pharma Summary GBI Research, the leading business ...

Industries : Pathology
Countries : World

Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD

$ 3 500
Industry report
November 2011
by GBI Research

Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD Summary GBI Research's report, ?Clinical Trial Recruitment in Respiratory Diseases - Most Clinical ...

Industries : Pathology
Countries : Brazil, India, China, World

Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology

$ 3 500
Industry report
November 2011
by GBI Research

Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology Summary GBI Research, the leading business intelligence provider, has released ...

Industries : Pathology
Countries : Japan, World, United States, Europe

Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth

$ 3 500
Industry report
October 2011
by GBI Research

Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth Summary GBI Research, the leading business intelligence ...

Industries : Pathology
Countries : World

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

$ 3 500
Industry report
October 2011
by GBI Research

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers Summary GBI Research's report ?Clinical Trial Recruitment in Dermatology ...

Industries : Pathology
Countries : Brazil, India, China

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

$ 3 500
Industry report
September 2011
by GBI Research

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth Summary GBI Research's report, ?Immunoglobulins Market ...

Industries : Pathology
Countries : World

Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade

$ 3 500
Industry report
September 2011
by GBI Research

Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology
Countries : Brazil, India, China

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia

$ 3 500
Industry report
September 2011
by GBI Research

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology
Countries : Brazil, India, China, World

Comparative Analysis of Marketed Drugs in Major Indications - Patent Cliff to Set Off Intense Price Competition in High Volume Markets

$ 3 500
Industry report
August 2011
by GBI Research

Comparative Analysis of Marketed Drugs in Major Indications - Patent Cliff to Set Off Intense Price Competition in High Volume Markets Summary GBI Research, the leading business intelligence provider, ...

Industries : Pathology

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development

$ 3 500
Industry report
July 2011
by GBI Research

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development Summary GBI Research, a leading business intelligence ...

Industries : Pathology
Countries : World

Specialty Pharmaceutical Industry - 2011 Yearbook

$ 3 500
Industry report
May 2011
by GBI Research

Summary GBI Research's "Specialty Pharmaceutical Industry - 2011 Yearbook? essentially provides insights on specialty pharmaceutical sales and price forecasts until 2017. The report provides in-depth therapeutics ...

Industries : Pathology
Countries : World

ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders

$ 3 500
Industry report
April 2011
by GBI Research

ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders Summary GBI Research's pharmaceutical report, ?ENT Disorders Market to ...

Industries : Pathology
Countries : World

Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market

$ 3 500
Industry report
April 2011
by GBI Research

Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market Summary GBI Research, the leading business intelligence provider, has released its latest ...

Industries : Pathology
Countries : World

Diabetes Care Devices Market to 2017 - Artificial Pancreas to Be the Key Technology Driver for the Market

$ 3 500
Industry report
April 2011
by GBI Research

Summary GBI Research's report, ?Diabetes Care Devices Market to 2017 - Artificial Pancreas to Be the Key Technology Driver for the Market? provides key data, information and analysis on the global Diabetes ...

Industries : Pathology
Countries : World

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market

$ 3 500
Industry report
January 2011
by GBI Research

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Summary GBI Research, the leading business intelligence ...

Industries : Pathology
Countries : China

... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...

» Read our Company Profiles

2 Companies

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States